• 11/25/2024

Biogen’s New Boss Is Delivering, but Stock Isn’t Pricing It in Yet

Wall Street Journal

The decision to buy Reata signals a new era under CEO Chris Viehbacher, and Wall Street’s skepticism presents an opportunity.

https://www.wsj.com/articles/biogens-new-boss-is-delivering-but-stock-isnt-pricing-it-in-yet-2ad9ceb6